Published in PLoS Negl Trop Dis on November 21, 2007
Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol (2010) 3.10
Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals. PLoS Pathog (2010) 1.90
G3BP1, G3BP2 and CAPRIN1 are required for translation of interferon stimulated mRNAs and are targeted by a dengue virus non-coding RNA. PLoS Pathog (2014) 1.84
Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J (2010) 1.67
The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol (2010) 1.47
IFI6 Inhibits Apoptosis via Mitochondrial-Dependent Pathway in Dengue Virus 2 Infected Vascular Endothelial Cells. PLoS One (2015) 1.46
Dengue virus inhibits immune responses in Aedes aegypti cells. PLoS One (2010) 1.35
Patterns of gene transcript abundance in the blood of children with severe or uncomplicated dengue highlight differences in disease evolution and host response to dengue virus infection. J Infect Dis (2009) 1.24
Potent host-directed small-molecule inhibitors of myxovirus RNA-dependent RNA-polymerases. PLoS One (2011) 1.18
Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife (2013) 1.10
Gene expression profiling of dengue infected human primary cells identifies secreted mediators in vivo. J Med Virol (2009) 1.08
Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism. PLoS Negl Trop Dis (2010) 1.05
Acute dengue virus 2 infection in Gabonese patients is associated with an early innate immune response, including strong interferon alpha production. BMC Infect Dis (2010) 1.04
Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severity. PLoS Negl Trop Dis (2013) 1.01
Activation of MDL-1 (CLEC5A) on immature myeloid cells triggers lethal shock in mice. J Clin Invest (2011) 1.01
Endothelial cells elicit immune-enhancing responses to dengue virus infection. J Virol (2012) 1.00
Characterization of early host responses in adults with dengue disease. BMC Infect Dis (2011) 0.99
Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol (2011) 0.97
Viperin is induced following dengue virus type-2 (DENV-2) infection and has anti-viral actions requiring the C-terminal end of viperin. PLoS Negl Trop Dis (2013) 0.97
Roles for endothelial cells in dengue virus infection. Adv Virol (2012) 0.95
Host genetic susceptibility to severe dengue infection. Trop Med Health (2011) 0.94
Using blood informative transcripts in geographical genomics: impact of lifestyle on gene expression in fijians. Front Genet (2012) 0.94
Host cell transcriptome profile during wild-type and attenuated dengue virus infection. PLoS Negl Trop Dis (2013) 0.93
How flaviviruses activate and suppress the interferon response. Viruses (2010) 0.92
Global transcriptomic analysis of human neuroblastoma cells in response to enterovirus type 71 infection. PLoS One (2013) 0.92
Targeting host factors to treat West Nile and dengue viral infections. Viruses (2014) 0.92
Dengue virus type 3 isolated from a fatal case with visceral complications induces enhanced proinflammatory responses and apoptosis of human dendritic cells. J Virol (2011) 0.91
Progress in the identification of dengue virus entry/fusion inhibitors. Biomed Res Int (2014) 0.91
Cells in dengue virus infection in vivo. Adv Virol (2010) 0.90
Viperin is highly induced in neutrophils and macrophages during acute and chronic lymphocytic choriomeningitis virus infection. J Immunol (2010) 0.90
Molecular profiling of T-helper immune genes during dengue virus infection. Virol J (2008) 0.86
Applications of high-throughput genomics to antiviral research: evasion of antiviral responses and activation of inflammation during fulminant RNA virus infection. Antiviral Res (2009) 0.85
High-throughput quantitative proteomic analysis of dengue virus type 2 infected A549 cells. PLoS One (2014) 0.83
BST2/tetherin inhibits dengue virus release from human hepatoma cells. PLoS One (2012) 0.82
The 'ubiquitous' reality of vector immunology. Cell Microbiol (2013) 0.82
Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction. Clin Vaccine Immunol (2013) 0.81
Clinical and immunological markers of dengue progression in a study cohort from a hyperendemic area in Malaysia. PLoS One (2014) 0.81
Transcriptome analysis reveals the host response to Schmallenberg virus in bovine cells and antagonistic effects of the NSs protein. BMC Genomics (2015) 0.80
Global gene expression profiling of myeloid immune cell subsets in response to in vitro challenge with porcine circovirus 2b. PLoS One (2014) 0.79
Tackling dengue fever: Current status and challenges. Virol J (2015) 0.79
Insights into the internalization and retrograde trafficking of Dengue 2 virus in BHK-21 cells. PLoS One (2011) 0.79
Chemoproteomic profiling identifies changes in DNA-PK as markers of early dengue virus infection. ACS Chem Biol (2012) 0.79
TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment. J Virol (2014) 0.78
Viperin: a radical response to viral infection. Biomol Concepts (2012) 0.78
Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection. PLoS Negl Trop Dis (2015) 0.78
A novel mosquito ubiquitin targets viral envelope protein for degradation and reduces virion production during dengue virus infection. Biochim Biophys Acta (2016) 0.77
Potential biomarkers for the clinical prognosis of severe dengue. Mem Inst Oswaldo Cruz (2013) 0.77
Differences in type I interferon signaling antagonism by dengue viruses in human and non-human primate cell lines. PLoS Negl Trop Dis (2015) 0.77
Characterization of RyDEN (C19orf66) as an Interferon-Stimulated Cellular Inhibitor against Dengue Virus Replication. PLoS Pathog (2016) 0.77
Interferon-induced HERC5 is evolving under positive selection and inhibits HIV-1 particle production by a novel mechanism targeting Rev/RRE-dependent RNA nuclear export. Retrovirology (2014) 0.76
Identification of RNA Binding Proteins Associated with Dengue Virus RNA in Infected Cells Reveals Temporally Distinct Host Factor Requirements. PLoS Negl Trop Dis (2016) 0.76
Production of Infectious Dengue Virus in Aedes aegypti Is Dependent on the Ubiquitin Proteasome Pathway. PLoS Negl Trop Dis (2015) 0.76
Cullin4 Is Pro-Viral during West Nile Virus Infection of Culex Mosquitoes. PLoS Pathog (2015) 0.76
Transcriptome meta-analysis reveals a dysregulation in extra cellular matrix and cell junction associated gene signatures during Dengue virus infection. Sci Rep (2016) 0.76
Cyclooxygenase-2 facilitates dengue virus replication and serves as a potential target for developing antiviral agents. Sci Rep (2017) 0.75
In vivo Ebola virus infection leads to a strong innate response in circulating immune cells. BMC Genomics (2016) 0.75
Discovery and Validation of Prognostic Biomarker Models to Guide Triage among Adult Dengue Patients at Early Infection. PLoS One (2016) 0.75
Aspects of T Cell-Mediated Immunity Induced in Mice by a DNA Vaccine Based on the Dengue-NS1 Antigen after Challenge by the Intracerebral Route. PLoS One (2016) 0.75
Genomic approaches for understanding dengue: insights from the virus, vector, and host. Genome Biol (2016) 0.75
Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein. Proc Natl Acad Sci U S A (2017) 0.75
Activation of Nrf2 by the dengue virus causes an increase in CLEC5A, which enhances TNF-α production by mononuclear phagocytes. Sci Rep (2016) 0.75
A tetravalent dengue nanoparticle stimulates antibody production in mice. J Nanobiotechnology (2012) 0.75
Primary dengue haemorrhagic fever in patients from northeast of Brazil is associated with high levels of interferon-β during acute phase. Mem Inst Oswaldo Cruz (2016) 0.75
Spectrum of disease outcomes in mice infected with YFV-17D. J Gen Virol (2015) 0.75
Monkey Viperin Restricts Porcine Reproductive and Respiratory Syndrome Virus Replication. PLoS One (2016) 0.75
IL-28 and IL-29 as protective markers in subject with dengue fever. Med Microbiol Immunol (2017) 0.75
Transcriptional Profiling Confirms the Therapeutic Effects of Mast Cell Stabilization in a Dengue Disease Model. J Virol (2017) 0.75
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res (2005) 13.37
DNA arrays for analysis of gene expression. Methods Enzymol (1999) 12.50
Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis (2000) 11.44
Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science (1995) 11.16
Structure of dengue virus: implications for flavivirus organization, maturation, and fusion. Cell (2002) 9.13
Dengue and dengue haemorrhagic fever. Lancet (1998) 7.31
Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med (1996) 6.36
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat Med (2003) 6.25
Human skin Langerhans cells are targets of dengue virus infection. Nat Med (2000) 5.74
Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A (2003) 5.05
A structural perspective of the flavivirus life cycle. Nat Rev Microbiol (2005) 5.02
Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res (2003) 4.90
Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med (1998) 4.52
Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci U S A (2000) 4.31
Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol (2005) 4.11
Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci U S A (2000) 3.83
Localization of dengue virus in naturally infected human tissues, by immunohistochemistry and in situ hybridization. J Infect Dis (2004) 3.81
Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol (2000) 3.61
Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol (2005) 3.31
Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever. J Infect Dis (2007) 2.89
Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol (2006) 2.76
Immunity by ubiquitylation: a reversible process of modification. Nat Rev Immunol (2005) 2.56
Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A (2001) 2.49
Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc Natl Acad Sci U S A (2001) 2.44
Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology (2005) 2.23
Early Dengue infection and outcome study (EDEN) - study design and preliminary findings. Ann Acad Med Singapore (2006) 2.12
Development and evaluation of fluorogenic TaqMan reverse transcriptase PCR assays for detection of dengue virus types 1 to 4. J Clin Microbiol (2004) 2.01
Both CXCR3 and CXCL10/IFN-inducible protein 10 are required for resistance to primary infection by dengue virus. J Immunol (2006) 1.70
Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. J Virol (2002) 1.67
Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells. J Virol (2003) 1.65
Dengue. Curr Opin Infect Dis (2002) 1.54
Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation. Hepatology (2004) 1.50
The ubiquitin-proteasome pathway in viral infections. Can J Physiol Pharmacol (2006) 1.38
Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J Immunol (2006) 1.38
Optimal gene expression analysis by microarrays. Cancer Cell (2002) 1.34
Fulminant hepatitis in dengue haemorrhagic fever. J Clin Virol (2007) 1.33
Interaction with a ubiquitin-like protein enhances the ubiquitination and degradation of hepatitis C virus RNA-dependent RNA polymerase. J Virol (2003) 1.32
Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by interferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur J Immunol (1997) 1.31
Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome. Clin Chem (2005) 1.28
Methodological study of affine transformations of gene expression data with proposed robust non-parametric multi-dimensional normalization method. BMC Bioinformatics (2006) 1.26
E6AP ubiquitin ligase mediates ubiquitylation and degradation of hepatitis C virus core protein. J Virol (2006) 1.19
The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9). J Biomed Sci (2007) 1.09
Retracted Dengue virus-induced apoptosis in hepatic cells is partly mediated by Apo2 ligand/tumour necrosis factor-related apoptosis-inducing ligand. J Gen Virol (2005) 1.00
Microarray and real-time RT-PCR analyses of a novel set of differentially expressed human genes in ECV304 endothelial-like cells infected with dengue virus type 2. J Virol Methods (2005) 0.95
Gene expression in human macrophages infected with dengue virus serotype-2. Scand J Immunol (2004) 0.95
Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest. J Biol Chem (2002) 0.94
Cell-specific inhibition of paramyxovirus maturation by proteasome inhibitors. Microbiol Immunol (2005) 0.88
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet (2006) 20.76
A global map of p53 transcription-factor binding sites in the human genome. Cell (2006) 20.65
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A (2005) 13.54
Genomewide association study of leprosy. N Engl J Med (2009) 8.17
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res (2008) 8.17
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res (2006) 8.08
Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell (2007) 7.05
Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci U S A (2011) 6.16
Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet (2007) 5.85
Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev (2007) 5.79
Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci U S A (2006) 5.27
Fusion transcripts and transcribed retrotransposed loci discovered through comprehensive transcriptome analysis using Paired-End diTags (PETs). Genome Res (2007) 4.99
RNA viral community in human feces: prevalence of plant pathogenic viruses. PLoS Biol (2006) 4.93
NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell (2008) 4.88
Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet (2010) 4.65
BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. J Clin Oncol (2012) 3.86
A 12-month phase 3 study of pasireotide in Cushing's disease. N Engl J Med (2012) 3.85
Integrated genome-wide DNA copy number and expression analysis identifies distinct mechanisms of primary chemoresistance in ovarian carcinomas. Clin Cancer Res (2009) 3.45
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses. Proc Natl Acad Sci U S A (2003) 3.18
The epidemiology of respiratory syncytial virus lower respiratory tract infections in children less than 5 years of age in Indonesia. Pediatr Infect Dis J (2011) 2.82
Genomic epidemiology of a dengue virus epidemic in urban Singapore. J Virol (2009) 2.74
Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution. J Virol (2007) 2.65
Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol (2006) 2.55
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol (2013) 2.48
A genome-wide association study identifies novel and functionally related susceptibility Loci for Kawasaki disease. PLoS Genet (2009) 2.45
MicroRNA-134 modulates the differentiation of mouse embryonic stem cells, where it causes post-transcriptional attenuation of Nanog and LRH1. Stem Cells (2007) 2.40
Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease. Nat Genet (2010) 2.32
A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis (2007) 2.22
An adenosine nucleoside inhibitor of dengue virus. Proc Natl Acad Sci U S A (2009) 2.20
Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep (2010) 2.14
Early Dengue infection and outcome study (EDEN) - study design and preliminary findings. Ann Acad Med Singapore (2006) 2.12
Diagnosis of childhood tuberculosis and host RNA expression in Africa. N Engl J Med (2014) 2.12
Strategies for development of Dengue virus inhibitors. Antiviral Res (2010) 2.11
Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation. Mol Cell (2007) 2.05
Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet (2011) 2.00
Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. EMBO J (2008) 1.99
Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness. PLoS Negl Trop Dis (2008) 1.99
Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet (2011) 1.97
Structure of the Dengue virus helicase/nucleoside triphosphatase catalytic domain at a resolution of 2.4 A. J Virol (2005) 1.96
Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy. Nat Genet (2011) 1.95
Detection of tuberculosis in HIV-infected and -uninfected African adults using whole blood RNA expression signatures: a case-control study. PLoS Med (2013) 1.91
Clinical utility of PCR for common viruses in acute respiratory illness. Pediatrics (2014) 1.86
Crystal structure of the NS3 protease-helicase from dengue virus. J Virol (2007) 1.84
Dengue virus surveillance for early warning, Singapore. Emerg Infect Dis (2010) 1.81
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer. Clin Cancer Res (2011) 1.79
Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks. N Engl J Med (2010) 1.79
Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc Natl Acad Sci U S A (2003) 1.78
RCP is a human breast cancer-promoting gene with Ras-activating function. J Clin Invest (2009) 1.71
Functional profiling of recombinant NS3 proteases from all four serotypes of dengue virus using tetrapeptide and octapeptide substrate libraries. J Biol Chem (2005) 1.70
Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J Virol (2008) 1.65
Genetic association and expression studies indicate a role of toll-like receptor 8 in pulmonary tuberculosis. PLoS Genet (2008) 1.65
Cholesterol biosynthesis modulation regulates dengue viral replication. Virology (2009) 1.64
Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children. Crit Care Med (2003) 1.61
A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother (2009) 1.59
Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis. PLoS One (2012) 1.58
Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers. PLoS One (2011) 1.57
Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy. Clin Infect Dis (2008) 1.55
Impact of vaccine-induced mucosal high-avidity CD8+ CTLs in delay of AIDS viral dissemination from mucosa. Blood (2005) 1.54
Amplicon-dependent CCNE1 expression is critical for clonogenic survival after cisplatin treatment and is correlated with 20q11 gain in ovarian cancer. PLoS One (2010) 1.54
Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. PLoS Comput Biol (2006) 1.53
Prolonged activation of virus-specific CD8+T cells after acute B19 infection. PLoS Med (2005) 1.53
Collagen-related genes influence the glaucoma risk factor, central corneal thickness. Hum Mol Genet (2010) 1.52
The early clinical features of dengue in adults: challenges for early clinical diagnosis. PLoS Negl Trop Dis (2011) 1.52
Copy number analysis identifies novel interactions between genomic loci in ovarian cancer. PLoS One (2010) 1.50
A method for full genome sequencing of all four serotypes of the dengue virus. J Virol Methods (2010) 1.48
Oxidation of 7,8-dihydro-8-oxoguanine affords lesions that are potent sources of replication errors in vivo. Biochemistry (2002) 1.48
The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults. J Virol (2010) 1.47
Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet (2010) 1.45
TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J Immunol (2006) 1.45
Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol (2006) 1.44
CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat (2011) 1.43
Dengue virus serotype infection specifies the activation of the unfolded protein response. Virol J (2007) 1.41
Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha/beta-recognized nuclear localization sequences is integral to viral infection. Traffic (2007) 1.41
Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target. Antiviral Res (2008) 1.41
Tandem duplication of chromosomal segments is common in ovarian and breast cancer genomes. J Pathol (2012) 1.41
Detection of human parvovirus B19 infection in first-trimester fetal loss. Obstet Gynecol (2002) 1.40
Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc Natl Acad Sci U S A (2011) 1.40
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin. Cancer Res (2012) 1.39
Effect of continuous ozone injection on performance and biomass accumulation of biofilters treating gaseous toluene. Appl Microbiol Biotechnol (2014) 1.39
Effect of continuous ozone injection on performance and biomass accumulation of biofilters treating gaseous toluene. Appl Microbiol Biotechnol (2014) 1.38
A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients. J Infect Dis (2012) 1.37
Dengue virus NS4B interacts with NS3 and dissociates it from single-stranded RNA. J Gen Virol (2006) 1.36